OCT 05, 2016 2:24 PM PDT

Kidney Cancer Drug Repurposed to Treat Other Cancers

WRITTEN BY: Xuan Pham
A drug that’s approved for the treatment of kidney cancer could find renewed purpose against other cancer types too. After scrutinizing hundreds of drugs for common cell signaling pathways, researcher in Norway found that the same drug that fights kidney cancer – axitini – could also be effective aginst breast, prostate, and colorectal cancers.


Perhaps one of the best outcomes for pharmacologists is the discovery that common, pre-existing drugs could treat new conditions. This is the impetus behind the growing field of research known as “drug repurposing.”
 
Because so much money and time are spent for every drug that’s on the market, finding new uses for these commercially available drug effectively reduces the burden on the industry and patients could have more options sooner rather than later.
 
The team at Norway honed in on axitini only after screening an impressive 500 known compounds. They were looking for drugs that could block growth signals that allow cancer cells to proliferate without control. In this screen, axitini stood out as having an alternate mechanism of action that was previously unknown.
 
Axitini is a known tyrosine kinase inhibitor – it blocks the activation of many other downstream signals in the cell. Pertaining to kidney cancer, axitini stops angiogenesis – the process by which tumors grow new blood vessels.
 
But the research team found that axitini also blocks a signaling pathway known as Wnt signaling. Mutations in this pathway are associated with various conditions, including breast and prostate cancer, which have prompted research into finding suitable Wnt inhibitors. It appears then, that the Norway scientists may have found such an inhibitor. And the best part, we already know that axitini is safe to use in people.
 

When a pre-existing drug shows promise for a new disease, things tend to move much faster. Because toxicity and pharmacokinetics have been established, the time for it to reach patients should be cut dramatically. This could means years shaved off of moving a drug through the pipeline to get to the market.
 
The technique of scanning old drugs for new pathways may also have proved more fruitful, as the team hinted that there could be 3 to 4 more candidates to be on the look out for in the future.

Additional sources: MNT, University of Bergen
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 25, 2021
Chemistry & Physics
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
AUG 25, 2021
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
A new study from the University of Huddersfield shows promising breakthroughs on the use of self-assembling molecules as ...
SEP 23, 2021
Drug Discovery & Development
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
SEP 23, 2021
The FDA approves the first and only oral treatment for a certain non-small cell lung cancer.
Last week, the United States Food and Drug Administration (FDA) granted approval for the first oral therapy to ...
SEP 30, 2021
Cancer
Gut Microbiota Influences Colon Cancer Development
SEP 30, 2021
Gut Microbiota Influences Colon Cancer Development
The gut microbiome consists of all the microorganisms living in an individual’s digestive system. Various factors ...
OCT 11, 2021
Cancer
Different Cancer Types Metastasize to Specific Regions of the Brain
OCT 11, 2021
Different Cancer Types Metastasize to Specific Regions of the Brain
Metastatic cancer occurs when cancer spreads from its original site of origin to a distant location in the body. Wh ...
OCT 25, 2021
Cancer
Could Pomegranates Play a Role in Cancer Prevention or Treatment?
OCT 25, 2021
Could Pomegranates Play a Role in Cancer Prevention or Treatment?
Pomegranate (Punica granatum L) is an ancient fruit grown primarily in western Asia and Mediterranean regions.  ...
NOV 17, 2021
Cancer
Turkey, Tryptophan, and Cancer
NOV 17, 2021
Turkey, Tryptophan, and Cancer
As many people start to plan their Thanksgiving dinners, there will inevitably be a lot of talk about the turkey.  ...
Loading Comments...